Cargando…

Biglycan Promotes Cancer Stem Cell Properties, NFκB Signaling and Metastatic Potential in Breast Cancer Cells

SIMPLE SUMMARY: Breast cancer stem cells (BCSCs) are a small sub-population of cells within tumors with high metastatic potential. We identified biglycan (BGN) as a prospective molecular target in BCSCs that regulates the aggressive phenotypes of these cells. These findings establish a foundation fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manupati, Kanakaraju, Paul, Ritama, Hao, Mingang, Haas, Michael, Bian, Zhaoqun Christine, Holm, Tammy M., Guan, Jun-Lin, Yeo, Syn Kok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773822/ https://www.ncbi.nlm.nih.gov/pubmed/35053617 http://dx.doi.org/10.3390/cancers14020455

Ejemplares similares

FAK signaling in Cancer-Associated Fibroblasts promotes breast cancer cell migration and metastasis by exosomal miRNAs-mediated intercellular communication
por: Wu, Hsin-Jung, et al.
Publicado: (2020)

Targeting Autophagy in Thyroid Cancer: EMT, Apoptosis, and Cancer Stem Cells
por: Holm, Tammy M., et al.
Publicado: (2022)

Single-cell RNA-sequencing reveals distinct patterns of cell state heterogeneity in mouse models of breast cancer
por: Yeo, Syn Kok, et al.
Publicado: (2020)

FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors
por: Paul, Ritama, et al.
Publicado: (2020)

Correction to: FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors
por: Paul, Ritama, et al.
Publicado: (2020)

Breast cancer dataset with biomarker Biglycan
por: Silva Neto, Pedro Clarindo da, et al.
Publicado: (2023)

Expression and the Prognostic Value of Biglycan in Gastric Cancer
por: Hu, Sizhe, et al.
Publicado: (2022)

Biglycan and reduced glycolysis are associated with breast cancer cell dormancy in the brain
por: Sunderland, Ashley, et al.
Publicado: (2023)

Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan
por: Maishi, Nako, et al.
Publicado: (2016)

Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer
por: Morimoto, Hirofumi, et al.
Publicado: (2021)

Negative Control of Cell Migration by Rac1b in Highly Metastatic Pancreatic Cancer Cells Is Mediated by Sequential Induction of Nonactivated Smad3 and Biglycan
por: Otterbein, Hannah, et al.
Publicado: (2019)

The Role of Decorin and Biglycan Signaling in Tumorigenesis
por: Diehl, Valentina, et al.
Publicado: (2021)

Biglycan regulates bone development and regeneration
por: Shainer, Reut, et al.
Publicado: (2023)

NF-κB Signaling Is Regulated by Fucosylation in Metastatic Breast Cancer Cells
por: Doud, Emma H., et al.
Publicado: (2020)

Regulation of immune checkpoint blockade efficacy in breast cancer by FIP200: A canonical-autophagy-independent function
por: Yeo, Syn Kok, et al.
Publicado: (2020)

Biglycan enhances gastric cancer invasion by activating FAK signaling pathway
por: Hu, Lei, et al.
Publicado: (2014)

Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer
por: Niedworok, Christian, et al.
Publicado: (2013)

Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers
por: Zhao, Shou-Feng, et al.
Publicado: (2020)

Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells
por: Yamamoto, K, et al.
Publicado: (2012)

Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells
por: Subbarayan, Karthikeyan, et al.
Publicado: (2022)

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer
por: Jacobsen, Frank, et al.
Publicado: (2017)

Biglycan: A Multivalent Proteoglycan Providing Structure and Signals
por: Nastase, Madalina V., et al.
Publicado: (2012)

Biglycan expression and its function in human ligamentum flavum
por: Salimi, Hamidullah, et al.
Publicado: (2021)

Diabetes mellitus is associated with liver metastasis of colorectal cancer through production of biglycan-rich cancer stroma
por: Fujiwara-Tani, Rina, et al.
Publicado: (2020)

The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness
por: Pinto, Filipe, et al.
Publicado: (2021)

The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican
por: Berdiaki, Aikaterini, et al.
Publicado: (2023)

Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis
por: Barreto, Goncalo, et al.
Publicado: (2015)

Decorin knockdown is beneficial for aged tendons in the presence of biglycan expression
por: Beach, Zakary M., et al.
Publicado: (2022)

The NF-κB Pathway and Cancer Stem Cells
por: Rinkenbaugh, Amanda L., et al.
Publicado: (2016)

Thymidine phosphorylase activates NFκB and stimulates the expression of angiogenic and metastatic factors in human cancer cells
por: Tabata, Sho, et al.
Publicado: (2014)

Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease
por: Fadic, Ricardo, et al.
Publicado: (2006)

Autophagy gene FIP200 in neural progenitors non–cell autonomously controls differentiation by regulating microglia
por: Wang, Chenran, et al.
Publicado: (2017)

To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator
por: Sorriento, Daniela, et al.
Publicado: (2012)

A Necessary Role for Increased Biglycan Expression during L1-Mediated Colon Cancer Progression
por: Saha, Arka, et al.
Publicado: (2021)

Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2022)

Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases
por: Genovese, Federica, et al.
Publicado: (2013)

Identification of the effector domain of biglycan that facilitates BMP-2 osteogenic function
por: Jongwattanapisan, Prapaporn, et al.
Publicado: (2018)

Serum Decorin, Biglycan, and Extracellular Matrix Component Expression in Preterm Birth
por: Mennella, Jenna M., et al.
Publicado: (2020)

Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma
por: Shao, Changming, et al.
Publicado: (2021)

IPSC reprogramming of two patients with spondyloepimetaphyseal dysplasia (SEMD, biglycan type)
por: De Kinderen, Pauline, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sbpeddipvqraa8bhi6brkbkitj